J1932
HCPCSInj, lanreotide, (cipla) 1mg
Official HCPCS Level II long descriptor
Injection, lanreotide, (cipla), 1 mg
HCPCS Level II code J1932 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, lanreotide, (cipla) 1mg
Added to HCPCS: 2022-10-01
Nearby codes in J1
- J1835Itraconazole injection
- J1836Inj, metronidazole, 10 mg
- J1837Inj, posaconazole, 1 mg
- J1885Ketorolac tromethamine inj
- J1920Inj, labetalol hcl, 5mg
- J1921Inj labetalol hcl hikma, 5mg
- J1930Lanreotide injection
- J1931Laronidase injection
- J1938Inj, furosemide, 1 mg
- J1939Inj, bumetanide, 0.5 mg
- J1941Inj, furoscix, 20 mg
- J1943Inj., aristada initio, 1 mg
- J1944Aripiprazole lauroxil 1 mg
- J1950Leuprolide acetate /3.75 mg
- J1951Inj fensolvi 0.25 mg
- J1952Leuprolide inj, camcevi, 1mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.